Financial Enhancement Group’s Hershey HSY Stock Holding History

Financial Enhancement Group’s Portfolio HSY Stock Details HSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13	Closed	-$3K	–	206
2022 Q3	$3K	Hold	13	–	–	﹤0.01%	223
2022 Q2	$3K	Hold	13	–	–	﹤0.01%	221
2022 Q1	$3K	Buy	+13	New	+$2.64K	﹤0.01%	231
2020 Q1	–	Sell	-47,731	Closed	-$7.02M	–	293
2019 Q4	$7.02M	Buy	+47,731	New	+$7.08M	1.77%	22

Other funds holding HSY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Financial Enhancement Group's HSY Position: Q4 2022 in Review

Financial Enhancement Group sold out of Hershey (HSY) in Q4 2022, closing a stake of 13 shares — an estimated $3K sold.

Financial Enhancement Group first reported a position in HSY in Q4 2019 and held it in 4 quarters. The position peaked at $7.02M in Q4 2019. 1,293 funds tracked by Wall St. Rank hold HSY as of Q4 2022.

Financial Enhancement Group reported no remaining Hershey position as of Q4 2022 after selling out during the quarter.
Financial Enhancement Group sold 13 Hershey shares in Q4 2022, an estimated $3K.
Financial Enhancement Group first reported a position in Hershey in Q4 2019 and held it in 4 quarters.
Financial Enhancement Group's Hershey position peaked at $7.02M in Q4 2019.
1,293 funds tracked by Wall St. Rank held Hershey as of Q4 2022.

Based on Financial Enhancement Group's 13F filing for Q4 2022, filed 9 Feb 2023.